Several exploratory studies have evaluated the diagnostic potential of cytokine biomarkers other than IFN-γ for monitoring anti-TB treatment such as TNF-α18, or IFN- γ /TNF-α19, or IFN- γ inducible protein (IP)-1020. This evidence concerns the gene IFNG and tuberculosis.